Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis

BACKGROUND: To use competing analyses to estimate the prognostic value of KRAS mutation status in colorectal cancer (CRC) patients and to build nomogram for CRC patients who had KRAS testing. METHOD: The cohort was selected from the Surveillance, Epidemiology, and End Results database. Cumulative in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Dongjun, Wang, Yanmei, Zhu, Liyuan, Jin, Hongchuan, Wang, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271887/
https://www.ncbi.nlm.nih.gov/pubmed/32547859
http://dx.doi.org/10.7717/peerj.9149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271887/
https://www.ncbi.nlm.nih.gov/pubmed/32547859
http://dx.doi.org/10.7717/peerj.9149

Ejemplares similares